Legend Biotech Statistics Share Statistics Legend Biotech has 91.84M
shares outstanding. The number of shares has increased by 0.47%
in one year.
Shares Outstanding 91.84M Shares Change (YoY) 0.47% Shares Change (QoQ) 0.21% Owned by Institutions (%) 46.72% Shares Floating 81.38M Failed to Deliver (FTD) Shares 1,488 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 7.86M, so 4.28% of the outstanding
shares have been sold short.
Short Interest 7.86M Short % of Shares Out 4.28% Short % of Float 8.18% Short Ratio (days to cover) 8.55
Valuation Ratios The PE ratio is -16.81 and the forward
PE ratio is 50.66.
Legend Biotech's PEG ratio is
0.25.
PE Ratio -16.81 Forward PE 50.66 PS Ratio 4.74 Forward PS 1.9 PB Ratio 2.86 P/FCF Ratio -18.81 PEG Ratio 0.25
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Legend Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.62,
with a Debt / Equity ratio of 0.34.
Current Ratio 4.62 Quick Ratio 4.54 Debt / Equity 0.34 Debt / EBITDA -3.1 Debt / FCF -2.22 Interest Coverage -14.03
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $241.25K Profits Per Employee $-68.09K Employee Count 2,600 Asset Turnover 0.38 Inventory Turnover 9.81
Taxes Income Tax 18.89M Effective Tax Rate -11.95%
Stock Price Statistics The stock price has increased by -24.5% in the
last 52 weeks. The beta is 0.28, so Legend Biotech's
price volatility has been higher than the market average.
Beta 0.28 52-Week Price Change -24.5% 50-Day Moving Average 37.06 200-Day Moving Average 35.14 Relative Strength Index (RSI) 38.07 Average Volume (20 Days) 1,254,436
Income Statement In the last 12 months, Legend Biotech had revenue of 627.24M
and earned -177.03M
in profits. Earnings per share was -1.94.
Revenue 627.24M Gross Profit 392.66M Operating Income -303.24M Net Income -177.03M EBITDA -113.16M EBIT -136.52M Earnings Per Share (EPS) -1.94
Full Income Statement Balance Sheet The company has 286.75M in cash and 350.6M in
debt, giving a net cash position of -63.85M.
Cash & Cash Equivalents 286.75M Total Debt 350.6M Net Cash -63.85M Retained Earnings -1.66B Total Assets 1.69B Working Capital 984.41M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -144.03M
and capital expenditures -14.11M, giving a free cash flow of -158.14M.
Operating Cash Flow -144.03M Capital Expenditures -14.11M Free Cash Flow -158.14M FCF Per Share -1.73
Full Cash Flow Statement Margins Gross margin is 62.6%, with operating and profit margins of -48.35% and -28.22%.
Gross Margin 62.6% Operating Margin -48.35% Pretax Margin -25.21% Profit Margin -28.22% EBITDA Margin -18.04% EBIT Margin -48.35% FCF Margin -25.21%
